Cleveland Multiport Catheter

DEVICE3 trials

Sponsors

Michael Vogelbaum, MD, PhD

Conditions

Brain TumorGliomaHigh Grade GliomaMalignant GliomaWHO Grade III or IV Recurrent Glioma

Early Phase 1

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

CompletedNCT02278510

Michael Vogelbaum, MD, PhDMalignant Glioma, WHO Grade III or IV Recurrent Glioma

Start: 2014-12-09End: 2015-11-10Updated: 2017-03-31

Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection

TerminatedNCT02500459

Michael Vogelbaum, MD, PhDBrain Tumor, High Grade Glioma

Start: 2015-07-06End: 2018-11-19Updated: 2019-03-01

Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy

WithdrawnNCT03193463

Michael Vogelbaum, MD, PhDGlioma

Start: 2017-11-03End: 2018-11-19Updated: 2019-03-01

Related Papers

First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1

Journal of neurosurgery2018-04-0161 citations